- Filed
- Aug 19, 2024 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q2 2024 · Aug 19, 2024 | 7.73B sh |
| Short Term Debt | Q2 2024 · Jun 30, 2024 | $2.38M |
| Short Term Debt | Q2 2024 · Dec 31, 2023 | $680.67K |
| Cash And Equivalents | Q2 2024 · Jun 30, 2024 | $31.1K |
| Cash And Equivalents | Q2 2024 · Dec 31, 2023 | $68.57K |
| Current Liabilities | Q2 2024 · Jun 30, 2024 | $8.55M |
| Current Liabilities | Q2 2024 · Dec 31, 2023 | $8.3M |
| Total Liabilities | Q2 2024 · Jun 30, 2024 | $20.49M |
| Total Liabilities | Q2 2024 · Dec 31, 2023 | $17.72M |
| Current Assets | Q2 2024 · Jun 30, 2024 | $345.48K |
| Current Assets | Q2 2024 · Dec 31, 2023 | $403.1K |
| Total Assets | Q2 2024 · Jun 30, 2024 | $12.35M |
| Total Assets | Q2 2024 · Dec 31, 2023 | $11.52M |
| Shares Diluted | Q2 2024 · Jun 30, 2023 | 3.73B sh |
| Shares Diluted | Q2 2024 · Jun 30, 2023 | 3.73B sh |
| Capex | Q2 2024 · Jun 30, 2023 | $21.64K |
| Operating Cash Flow | Q2 2024 · Jun 30, 2023 | $35.49K |
| Stockholders Equity | Q2 2024 · Jun 30, 2023 | −$7.89M |
| Stockholders Equity | Q2 2024 · Mar 31, 2023 | −$9.43M |
| Stockholders Equity | Q2 2024 · Dec 31, 2022 | −$9.23M |
| Eps Diluted | Q2 2024 · Jun 30, 2023 | $0.00 |
| Eps Diluted | Q2 2024 · Jun 30, 2023 | $0.00 |
| Eps Basic | Q2 2024 · Jun 30, 2023 | $0.00 |
| Eps Basic | Q2 2024 · Jun 30, 2023 | $0.00 |
| Sga Expense | Q2 2024 · Jun 30, 2023 | $265.17K |
| Sga Expense | Q2 2024 · Jun 30, 2023 | $506.4K |
| Net Income | Q2 2024 · Jun 30, 2023 | −$407.87K |
| Operating Income | Q2 2024 · Jun 30, 2023 | $32.15K |
| Operating Income | Q2 2024 · Jun 30, 2023 | $107.17K |
| Revenue | Q2 2024 · Jun 30, 2023 | $1.57M |
| Revenue | Q2 2024 · Jun 30, 2023 | $2.87M |